Innolake Biopharm
3 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Study of the ILB-3101 in Patients with Advanced Solid Tumors (NCT06426680) | Innolake Biopharm | 2024-10-30 |
| A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies (NCT05955105) | Innolake Biopharm | 2023-07-25 |
| A Study of ILB2109 in Patients With Advanced Solid Malignancies (NCT05278546) | Innolake Biopharm | 2022-04-11 |
Track Innolake Biopharm automatically
Every clearance here is in the API, with alerts when new ones post.